Anti-PD-1 With or Without Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

被引：0
|
作者：
Teng, F. [1 ]
Wang, P. [2 ,3 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[3] Shandong Univ, Shandong Canc Hosp & Inst, Cheeloo Coll Med, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2943
引用
收藏
页码：E455 / E456
页数：2
相关论文
共 50 条
  • [31] Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case report
    Xu, Shiting
    Shukuya, Takehito
    Shimamura, Shoko
    Hayashi, Takuo
    Sato, Yoshihiko
    Shiozaki, Hitomi
    Nishioki, Toshihiko
    Nishino, Koichi
    Kato, Motoyasu
    Hattori, Aritoshi
    Shimada, Naoko
    Suzuki, Kenji
    Kitano, Shigehisa
    Takahashi, Kazuhisa
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (03) : 666 - 672
  • [32] Retreatment with anti-PD-1 antibody in non-small cell lung cancer patients previously treated with anti-PD-L1 antibody
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    THORACIC CANCER, 2020, 11 (01) : 15 - 18
  • [33] Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies
    Fujita, Kohei
    Uchida, Naohiro
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    ANTICANCER RESEARCH, 2019, 39 (07) : 3917 - 3921
  • [34] Surgery for oligometastatic non-small cell lung cancer
    Antonoff, Mara B.
    Deboever, Nathaniel
    Werner, Raphael
    Altan, Mehmet
    Gomez, Daniel
    Opitz, Isabelle
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 167 (02):
  • [35] Oligometastatic disease of non-small cell lung cancer
    Schmid, Severin
    Passlick, Bernward
    Stuschke, Martin
    Griesinger, Frank
    ONKOLOGE, 2018, 24 (12): : 992 - 1002
  • [36] SBRT for Oligometastatic Non-Small Cell Lung Cancer
    Herman, M. P.
    Dagan, R.
    Yeung, A. R.
    Bryant, C.
    Morris, C. G.
    Okunieff, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S609 - S610
  • [37] Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
    Dohopolski, Michael
    Iyengar, Puneeth
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5944 - 5953
  • [38] Classifying Oligometastatic Non-Small Cell Lung Cancer
    Blumenthaler, Alisa N.
    Antonoff, Mara B.
    CANCERS, 2021, 13 (19)
  • [39] SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC)
    Mak, Ka-Man
    McDonald, Fiona
    Teague, Jonathan
    Faivre-Finn, Corinne
    Forster, Martin
    Hanna, Gerard
    Moinuddin, Syed
    Conibear, John
    Harden, Susan
    Popat, Sanjay
    Califano, Raffaele
    Farrelly, Laura
    Counsell, Nicholas
    Saron, T. M. G.
    LUNG CANCER, 2022, 165 : S71 - S71
  • [40] Ginseng polysaccharides circumvent acquired resistance to anti-PD-1 immunotherapy in patients with non-small cell lung cancer
    Huang, Jumin
    Wang, Ziming
    Li, Feng
    Wang, Huiting
    Xiang, Yang
    Li, Runze
    Xie, Chun
    Wang, Yuwei
    Jiang, Zhihong
    Liang, Wenhua
    Cao, Yabing
    Leung, Elaine Lai-Han
    PHARMACOLOGICAL RESEARCH, 2025, 212
12345